52 related articles for article (PubMed ID: 3496062)
1. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs.
Carson JL; Strom BL; Morse ML; West SL; Soper KA; Stolley PD; Jones JK
Arch Intern Med; 1987 Jun; 147(6):1054-9. PubMed ID: 3496062
[TBL] [Abstract][Full Text] [Related]
2. Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits.
Gwee KA; Goh V; Lima G; Setia S
J Pain Res; 2018; 11():361-374. PubMed ID: 29491719
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.
Wallace JL
World J Gastroenterol; 2013 Mar; 19(12):1861-76. PubMed ID: 23569332
[TBL] [Abstract][Full Text] [Related]
4. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project).
Castellsague J; Riera-Guardia N; Calingaert B; Varas-Lorenzo C; Fourrier-Reglat A; Nicotra F; Sturkenboom M; Perez-Gutthann S;
Drug Saf; 2012 Dec; 35(12):1127-46. PubMed ID: 23137151
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic ulcers are neither meaningful nor validated as a surrogate for clinically significant upper gastrointestinal harm.
Graham DY
Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1147-50. PubMed ID: 19559818
[No Abstract] [Full Text] [Related]
6. COX-2: where are we in 2003?--distinction from NSAIDs becoming blurred.
Day R
Arthritis Res Ther; 2003; 5(3):116-9. PubMed ID: 12723976
[TBL] [Abstract][Full Text] [Related]
7. Rheumatology: 7. Basics of therapy.
Huang SH
CMAJ; 2000 Aug; 163(4):417-23. PubMed ID: 10976259
[No Abstract] [Full Text] [Related]
8. Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing.
Collet JP; Sharpe C; Belzile E; Boivin JF; Hanley J; Abenhaim L
Br J Cancer; 1999 Sep; 81(1):62-8. PubMed ID: 10487613
[TBL] [Abstract][Full Text] [Related]
9. Pharmacoeconomics of chronic nonmalignant pain.
Zagari MJ; Mazonson PD; Longton WC
Pharmacoeconomics; 1996 Oct; 10(4):356-77. PubMed ID: 10163578
[TBL] [Abstract][Full Text] [Related]
10. Misoprostol: pharmacoeconomics of its use as prophylaxis against gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs.
Barradell LB; Whittington R; Benfield P
Pharmacoeconomics; 1993 Feb; 3(2):140-71. PubMed ID: 10146962
[TBL] [Abstract][Full Text] [Related]
11. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.
Henry D; Lim LL; Garcia Rodriguez LA; Perez Gutthann S; Carson JL; Griffin M; Savage R; Logan R; Moride Y; Hawkey C; Hill S; Fries JT
BMJ; 1996 Jun; 312(7046):1563-6. PubMed ID: 8664664
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis.
Goggin PM; Collins DA; Jazrawi RP; Jackson PA; Corbishley CM; Bourke BE; Northfield TC
Gut; 1993 Dec; 34(12):1677-80. PubMed ID: 8282254
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal antiinflammatory drugs and upper gastrointestinal hemorrhage in an urban hospital.
Klein WA; Krevsky B; Klepper L; Ljubich P; Niewiarowski TJ; Rothstein KD; Dabezies MA; Fisher RS
Dig Dis Sci; 1993 Nov; 38(11):2049-55. PubMed ID: 8223081
[TBL] [Abstract][Full Text] [Related]
14. Differences in NSAID tolerability profiles. Fact or fiction?
Skeith KJ; Wright M; Davis P
Drug Saf; 1994 Mar; 10(3):183-95. PubMed ID: 8043221
[No Abstract] [Full Text] [Related]
15. Epidemiology of gastrointestinal damage associated with nonsteroidal anti-inflammatory drugs.
Willett LR; Carson JL; Strom BL
Drug Saf; 1994 Feb; 10(2):170-81. PubMed ID: 8011182
[TBL] [Abstract][Full Text] [Related]
16. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
Friedel HA; Langtry HD; Buckley MM
Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
[TBL] [Abstract][Full Text] [Related]
17. Histological findings in gastric mucosa in patients treated with non-steroidal anti-inflammatory drugs.
Caselli M; LaCorte R; DeCarlo L; Aleotti A; Trevisani L; Ruina M; Trotta F; Alvisi V
J Clin Pathol; 1995 Jun; 48(6):553-5. PubMed ID: 7665699
[TBL] [Abstract][Full Text] [Related]
18. From peptic ulcer disease to NSAID gastropathy. An evolving nosology.
Roth SH
Drugs Aging; 1995 May; 6(5):358-67. PubMed ID: 7647425
[TBL] [Abstract][Full Text] [Related]
19. Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.
Nash J; Lambert L; Deakin M
Drugs; 1994 Jun; 47(6):862-71. PubMed ID: 7521828
[TBL] [Abstract][Full Text] [Related]
20. Gastric tolerability of nimesulide. A double-blind comparison of 2 oral dosage regimens and placebo.
Marini U; Spotti D
Drugs; 1993; 46 Suppl 1():249-52. PubMed ID: 7506184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
